Inactive Instrument
Raptor Pharmaceutical Corp Stock
Stocks
US75382F1066
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
DFI | Director of Finance/CFO | 61 | 2016-10-24 |
| Corporate Officer/Principal | 64 | 2013-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
BRD | Director/Board Member | 61 | 2016-10-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.52% | -7.16% | +51.66% | +67.41% | 65B | |
| +1.52% | +6.83% | +10.89% | +79.30% | 51.2B | |
| +0.30% | -0.46% | -0.03% | +61.89% | 51.19B | |
| -0.77% | +0.97% | +24.86% | +41.77% | 43.93B | |
| +0.81% | +6.00% | +16.58% | +134.08% | 41.96B | |
| +2.41% | -6.07% | +237.29% | +528.17% | 38.14B | |
| +2.16% | +10.36% | +18.92% | +59.70% | 33.24B | |
| -0.90% | -10.49% | +37.09% | +1.80% | 25.2B | |
| +1.60% | +2.21% | +27.96% | +28.00% | 22.5B | |
| Average | +0.90% | +0.14% | +47.25% | +111.35% | 41.37B | |
| Weighted average by Cap. | +0.92% | +0.04% | +45.51% | +112.46% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
